# Heartbeat Labs

> Heartbeat Labs is a VC fund in Berlin backing Health Care and Medical Device. See 10 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Berlin, Germany
- Total investments: 10
- Last investment: Nov 2022
- Lead investor: 20%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/18158744
- X (Twitter): https://twitter.com/heartbeatlabs
- Website: https://www.heartbeatlabs.com/
- Facebook: https://www.facebook.com/HeartbeatLabs

Heartbeat Labs is a healthcare company builder based in Berlin. Their agile teams combine entrepreneurs, medical specialists and technology experts to launch several digital health companies per year. They provide seed funding of €0.5 to €5 million, access to a unique network of investors and operational expertise in marketing, HR, finance,regulatory affairs and more. Their team has the experience of building more than 20 successful internet companies that have brought the advantages of digitization to industries such as financial services and advertising.

## Contacts

5 contacts available for Heartbeat Labs. Shizune tracks 5 team members at Heartbeat Labs. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/heartbeat-labs?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 7 | 70% |
| Medical Device | 3 | 30% |
| Medical | 2 | 20% |
| Software | 2 | 20% |
| Biotechnology | 2 | 20% |

21 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 5 | 50% |
| Seed | 3 | 30% |
| Funding Round | 2 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 6 | 60% |
| India | 1 | 10% |
| United States | 1 | 10% |
| United Kingdom | 1 | 10% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Chad Jennings | CPO - Chief Product Officer | 0 | — |
| Hendrik Krawinkel | Co-founder and Managing Director | 0 | — |
| Jan Beckers | Co-founder and Chairman | 6 | https://shizune.co/investors/profile/jan-beckers |
| Johannes Keienburg | Managing Director | 0 | — |
| Stephanie Kaiser | Founder and Managing Director | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Betriebsarzt Service | Betriebsarzt Service offer you an uncomplicated, high-quality and reliable occupational health and safety-related care adapted to the needs of your employees and your company. They specialize in companies in growth and consolidation phases as well as industries that are subject to rapid change. Acute needs, such as the examination of electricalequipment, medical check-ups and all other occupational health and safety services, you can book with us individually! | $7M | Series A | Nov 22, 2022 |  |
| CureSkin | CureSkin is a mobile application for derma-care. It is uses computer vision to recommend treatment to patients who don’t have access to trained professionals. | $5M | Series A | Mar 07, 2022 |  |
| Farmako | Farmako wants to become a vertically integrated leader in every European country that has created a legal basis for medical cannabis. The pharmaceutical industry will be changed worldwide through cannabinoid therapies. We plan to drive this change with a high demand on our employees and our products as well as at high speed. As the first Europeancompany in this field, we attach great importance to innovation through research and development. So that doctors, patients and pharmacists have more choice to choose the best possible therapy. |  | Seed | Dec 17, 2018 |  |
| Nebula Genomics | Nebula Genomics is a human genome sequencing and health big data company on a mission to usher in the era of genomic sequencing by building a large and trusted genomic and health data marketplace for consumers, researchers and the medical community. Using blockchain to ensure that consumers maintain control of their data and are compensated for itsuse, the Nebula marketplace will aggregate a critical mass of rich genetic information that researchers can analyze in order to accelerate drug development, streamline clinical trials, and usher in the era of truly personalized medicine. The company was founded by Harvard genomics pioneer George Church, along with Harvard researchers Dennis Grishin and Kamal Obbad. Founded in 2017, Nebula Genomics has offices in San Francisco, CA and Boston, MA and is backed by investors including Khosla Ventures, Arch Venture Partners, Fenbushi Capital, Mayfield, F-Prime Capital Partners, GreatPoint Ventures, Hemi Ventures and Mirae Asset. | $4.3M | Series A | Oct 10, 2018 |  |
| BetterDoc | BetterDoc is Germany's market leader for medical expert referrals. BetterDoc is generating, processing and analyzing all types of quality data of a health care system. These data are used to identify the best medical expert for the patient's individual health problem. BetterDoc is also measuring for each patient case the outcome quality("full quality loop"). |  |  | Oct 10, 2018 |  |
| Medlanes | Medlanes bring medicine itself online! Medlanes allows you to connect with a doctor from anywhere in the world at anytime. Simply download the Medlanes app and request medical advice online. |  | Series A | Mar 21, 2018 |  |
| Mimi Hearing Technologies | Mimi is the world's leading company for digital hearing tests and sound personalization. The Mimi apps are medical devices in Europe (CE, class 1). With over one million hearing test app downloads from 150 countries, it creates the world’s largest database of digital hearing profiles. With Mimi Defined™, a technology for sound personalizationcould be developed, which - despite the imperfections of human hearing - can optimize the individual hearing experience for everyone. Our software can be integrated into any audio product, from headphones to TVs, smartphones or streaming services. Mimi Hearing Technologies products and integrations have won numerous prestigious international awards, including the CES Innovation Award in Las Vegas (2019 & 2018), the Sonar+D Award for Innovation in Barcelona (2017), the StartUps & Developer Award at the San Francisco Music Tech Summit (2017), the IFA Berlin Prize for Audio Innovation (2017), first place in the Cannes Midem lab competition in the category "Music Discovery" (2016), and the company was a finalist at the Techcrunch Disrupt New York Startup Battlefield in 2014. More information at www.mimi.io |  | Series A | Mar 20, 2018 |  |
| Daatrics | Daatrics is a technology company that specializes in bringing creative, advanced technological solutions to caregivers and families.Daatrics' Neebo product line is the smallest form factor multi-function wearable devices aim to provide parents and carers with continuous child monitoring when close proximity supervision can't beachieved. |  | Seed | Oct 31, 2017 |  |
| CureSkin | CureSkin is a mobile application for derma-care. It is uses computer vision to recommend treatment to patients who don’t have access to trained professionals. |  | Seed | Aug 01, 2017 |  |
| Moodpath | You’re going through a difficult phase in life and are worried about your mental health? Moodpath is a leading depression app and accompanies you on your way out of depression.Moodpath screens your well-being by asking questions on a daily basis. The screening makes you more conscious about your thoughts, feelings and emotions.After two weeks,you receive an electronic doctor letter. This letter will make your conversation with a professional much easier.More than 150 psychological exercises and videos give you a better understanding of your moodpath and strengthen your mental health. |  |  | Jun 15, 2016 |  |

10 of 10 investments shown.

## Co-investors
- [Taver Capital Partners](https://shizune.co/investors/profile/gagarin-capital-partners) — VC Fund, 2 deals together
- [IONIQ](https://shizune.co/investors/profile/ioniq-group) — VC Fund, 2 deals together
- [Taver Capital Partners](https://shizune.co/investors/profile/taver-capital-partners) — VC Fund, 2 deals together
- [Y Combinator](https://shizune.co/investors/profile/y-combinator) — VC Fund, 2 deals together
- Enchant — VC Fund, 1 deal together
- [Fenbushi Capital](https://shizune.co/investors/profile/fenbushi-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Heartbeat Labs invest in?

Heartbeat Labs invests primarily in Health Care, Medical Device and Medical startups, most often at Series A and Seed stage. Most of the 10 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Heartbeat Labs?

Public channels for Heartbeat Labs include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Heartbeat Labs?

The team at Heartbeat Labs includes Chad Jennings (CPO - Chief Product Officer), Hendrik Krawinkel (Co-founder and Managing Director) and Jan Beckers (Co-founder and Chairman). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co